Nippon India Pharma Fund vs Quant Healthcare Fund Regular compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare TRI |
Turn Over | 21% | % |
Expense Ratio | 1.82 | 2.39 |
Manager | Sailesh Raj Bhan | Sanjeev Sharma |
ISIN Code | INF204K01968 | INF966L01CG3 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | -2.32% | -6.2% |
6 Month | -11.01% | -23.3% |
1 Year | 8.24% | 1.86% |
3 Year | 17.42% | - |
5 Year | 24.86% | - |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | -8.53% | -14.5% |
1 Year | -7.01% | -23.36% |
3 Year | 20.46% | - |
5 Year | 17.84% | - |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 18.19% | 55.41% |
3 Year | 20.5% | - |
5 Year | 20.36% | - |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 15.623% | - |
Sharp | 0.707% | - |
Beta | 0.908% | - |
Alpha | 0.486% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Sailesh Raj Bhan | Sanjeev Sharma |
Total AUM | ₹96086 Cr | ₹39731 Cr |
Fund Manage | 5 | 22 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.36231 | 3.06118 |
Large Cap | 38.72112 | 30.87031 |
Mid Cap | 32.7767 | 13.74693 |
Small Cap | 27.13989 | 52.32158 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 1.36231 | 3.06118 |
Healthcare | 98.63771 | 79.01947 |
Energy | - | 6.70687 |
Technology | - | 5.4462 |
Consumer Defensive | - | 5.76628 |
Top Comparisons
Tata Equity PE Fund Regular Plan -(Growth Option)
3Y Returns17.84%
HSBC Value Fund - Regular Growth
3Y Returns18.88%
Canara Robeco Emerging Equities - Regular Plan - Growth Option
3Y Returns13.56%
Sundaram Large and Midcap Fund Regular Plan - Growth
3Y Returns12.59%
WhiteOak Capital Multi Cap Fund - Regular (G)
3Y Returns0%
Edelweiss Multi Cap Fund - Regular (G)
3Y Returns0%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns5.62%
Axis Strategic Bond Fund - Regular Plan - Growth Option
3Y Returns6.88%